about
Multiple regions within the coxsackievirus and adenovirus receptor cytoplasmic domain are required for basolateral sortingGene therapy: light is finally in the tunnelRecent advances in cystic fibrosisA novel peptide, THALWHT, for the targeting of human airway epithelia.Engineering viral vectors to subvert the airway defense response.Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in miceJaagsiekte sheep retrovirus Env protein stabilizes retrovirus vectors against inactivation by lung surfactant, centrifugation, and freeze-thaw cycling.Common gene therapy viral vectors do not efficiently penetrate sputum from cystic fibrosis patients.Current status of gene therapy for cystic fibrosis pulmonary disease.CFTR trafficking and signaling in respiratory epithelium.Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathologyTowards the pharmacogenomics of cystic fibrosis.Gene therapy for airway diseases: continued progress toward identifying and overcoming barriers to efficiency.Protection of Cftr knockout mice from acute lung infection by a helper-dependent adenoviral vector expressing Cftr in airway epithelia.Comparative genomic sequence analysis of the human and mouse cystic fibrosis transmembrane conductance regulator genes.Lentivirus-mediated gene transfer to the respiratory epithelium: a promising approach to gene therapy of cystic fibrosis.Chronic Pseudomonas aeruginosa infection in cystic fibrosis airway disease: metabolic changes that unravel novel drug targets.New insights into the pathogenesis of intestinal dysfunction: secretory diarrhea and cystic fibrosis.Vectors for airway gene delivery.Glycocalyx restricts adenoviral vector access to apical receptors expressed on respiratory epithelium in vitro and in vivo: role for tethered mucins as barriers to lumenal infection.Challenges and advances in the development of inhalable drug formulations for cystic fibrosis lung disease.Pseudomonas aeruginosa infection in cystic fibrosis lung disease and new perspectives of treatment: a review.Retargeting the coxsackievirus and adenovirus receptor to the apical surface of polarized epithelial cells reveals the glycocalyx as a barrier to adenovirus-mediated gene transfer.Internalization of adenovirus by alveolar macrophages initiates early proinflammatory signaling during acute respiratory tract infection.The future of radiology.Chitosan as a nonviral gene delivery system. Structure-property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo.G-protein-coupled receptors as targets for gene transfer vectors using natural small-molecule ligands.Activation of cystic fibrosis transmembrane conductance regulator in rat epididymal epithelium by genistein.Methoxsalen stimulates electrogenic Cl- secretion in the mouse jejunum.Budesonide enhances repeated gene transfer and expression in the lung with adenoviral vectors.Gene transfer to adult human lung tissue ex vivo.Cystic fibrosis sputum: a barrier to the transport of nanospheres.Biodistribution and transgene expression with nonviral cationic vector/DNA complexes in the lungs.Airway gene transfer in mouse nasal-airways: importance of identification of epithelial type for assessment of gene transfer.Structural alterations of gene complexes by cystic fibrosis sputum.Pegylated GL67 lipoplexes retain their gene transfection activity after exposure to components of CF mucus.
P2860
Q24291163-F1B00CCA-07EF-4597-B740-812558791E5AQ27000091-5F3B2CBD-3828-4E43-B90E-303F57A10FB0Q28367361-785BA88F-E133-4AE3-B336-CBEE2AAFC971Q30651077-55B01469-DA13-4B63-A862-1D85610A8412Q33643006-CA8B71C3-D54D-43D3-ABF1-EFE7DD0841B3Q33853415-6C02E8C2-B9BE-4ADB-B9CF-859E8A4373C1Q33854928-43DAF38C-09A5-40C5-99CD-C1B94E30789AQ33921035-F1030A3E-6D30-42D3-9565-7CE7DDBB957DQ33975113-35CC3F01-F839-4185-9827-AD36C6BA297EQ34280472-3E236424-E95A-434B-A5F7-9DDB4629B94AQ34364942-2EC3497D-DB36-4092-A3F0-475BA1374B1CQ34609152-0FE0F568-B964-474B-917D-2EC697129F02Q34768922-42177FB0-4541-4626-ADE7-CB5A8E7AA6A9Q34787537-3204CB3A-ED3C-46C2-BFB5-87F995ABC3D3Q35009670-1F1F4FDB-A4FB-4A61-96DA-CD1D1989C88EQ35904439-826036F4-9CB2-4C3E-96BC-ED2B0BD8906EQ35917498-9061AB76-CC51-4B98-BBFB-2537F07E0E02Q36492006-88DB041C-5C6C-425A-8CFA-A5A7834A6108Q36780050-3E0ABDA1-2DE1-4A5D-9722-6FF099B6A08FQ37682958-FB4AD51D-25E0-4B88-BD78-13B765AFDFC4Q37849777-76A62190-9D19-4177-80EA-4975A28AD687Q38101836-BA915BD7-DDE0-4C01-B399-D56043F40CD0Q39591753-BB63BB70-745B-4D37-9522-96FA90705E36Q39593402-60EE634A-AED7-4416-BC0D-99A271315C8FQ39734374-CF45A97F-24EE-42EE-AF16-9E3FCF6EDDC9Q40783246-21BDAB3A-99CE-425D-B2B2-9ABDC982628EQ40876316-A971CE23-E6B0-4FB3-9B7B-AA321450184EQ42481531-9880ABA6-CE01-4340-95D9-B259BD6C6DD8Q42686204-0C142F7B-1D83-4B4F-804D-FDC5864DDCECQ43732345-8ED5C387-0F4B-4927-A278-A112230FE52BQ45867367-6133DBE0-3FCB-41A6-826B-B930D9DCBE64Q45872261-7441A2A9-AF57-4650-8B6F-F2D9F9D5275EQ45872473-2CE628F0-E26F-429A-8545-39864DA331B2Q45872985-9C734B39-8AAF-44B0-B528-23F7E1F78F50Q45879126-C9019A32-C86E-4F54-8DF3-BE29A4B9E28AQ45885263-28CCB68F-EC96-4E62-8E99-F8AED0ADD384
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Status of gene therapy for cystic fibrosis lung disease
@ast
Status of gene therapy for cystic fibrosis lung disease
@en
Status of gene therapy for cystic fibrosis lung disease.
@nl
type
label
Status of gene therapy for cystic fibrosis lung disease
@ast
Status of gene therapy for cystic fibrosis lung disease
@en
Status of gene therapy for cystic fibrosis lung disease.
@nl
prefLabel
Status of gene therapy for cystic fibrosis lung disease
@ast
Status of gene therapy for cystic fibrosis lung disease
@en
Status of gene therapy for cystic fibrosis lung disease.
@nl
P2860
P356
P1476
Status of gene therapy for cystic fibrosis lung disease
@en
P2093
R C Boucher
P2860
P304
P356
10.1172/JCI6330
P407
P577
1999-02-01T00:00:00Z